CARE Ratings Limited rating actionCARE Ratings Limited · PDF preserved by IndiaTicker
Archived PDF Company dossier
Orchid Pharma
NSE:ORCHPHARMA · ISIN INE191A01027
- Close
- ₹1,001.45 29 Jul 2026
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Orchid Pharma
Ratings & risks
Credit signals
Agency evidenceRating-action history
CARE Ratings Limited rating actionCARE Ratings Limited · PDF preserved by IndiaTicker
Archived PDF CARE Ratings Limited rating actionCARE Ratings Limited · PDF preserved by IndiaTicker
Archived PDF CARE Ratings Limited rating actionCARE Ratings Limited · discovered
Agency source CARE Ratings Limited rating actionCARE Ratings Limited · discovered
Agency source CARE Ratings Limited rating actionCARE Ratings Limited · discovered
Agency source CARE Ratings Limited rating actionCARE Ratings Limited · discovered
Agency source CARE Ratings Limited rating actionCARE Ratings Limited · discovered
Agency source CARE Ratings Limited rating actionCARE Ratings Limited · discovered
Agency source CARE Ratings Limited rating actionCARE Ratings Limited · discovered
Agency source CARE Ratings Limited rating actionCARE Ratings Limited · discovered
Agency source CARE Ratings Limited rating actionCARE Ratings Limited · discovered
Agency source CARE Ratings Limited rating actionCARE Ratings Limited · discovered
Agency source CARE Ratings Limited rating actionCARE Ratings Limited · discovered
Agency source CARE Ratings Limited · CARE reaffirms the ratings assigned to the bank facilities of Orchid Pharma Limited (Erstwhile Orchid Chemicals And Pharmaceuticals Limited)CARE Ratings Limited · discovered
Agency source CARE Ratings Limited · CARE revises the rating assigned to the long-term bank facilities of Orchid Chemicals And Pharmaceuticals LimitedCARE Ratings Limited · discovered
Agency source Risk research framework
Analyst reviewQuestions to test against evidence
Operating deterioration
HighTrack sector-specific operating metrics and reconcile them across reporting periods.
Funding and liquidity
HighReview debt maturity, repricing, liquidity and rating commentary where relevant.
Execution versus guidance
MediumCompare management statements with subsequent reported delivery.
Governance and key-person change
MediumConnect management transitions, related parties and auditor observations.